相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。[11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates
Laura Kuebler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease
Silvio R. Meier et al.
MOLECULAR IMAGING AND BIOLOGY (2021)
Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice
Sahar Roshanbin et al.
NEUROBIOLOGY OF AGING (2021)
Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
Rebecca Faresjo et al.
FLUIDS AND BARRIERS OF THE CNS (2021)
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S. Kariolis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle
Dag Sehlin et al.
FASEB JOURNAL (2020)
Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly
Irina Alafuzoff et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer's disease
Tobias Gustavsson et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Engineered antibodies: new possibilities for brain PET?
Dag Sehlin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain
Xiaotian T. Fang et al.
NEUROIMAGE (2019)
Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression
Amy E. Jolly et al.
NEUROIMAGE-CLINICAL (2019)
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John L. Robinson et al.
BRAIN (2018)
Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
Silvio R. Meier et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Efficient clearence of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
Stina Syvanen et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice
Sara Ekmark-Lewen et al.
BRAIN AND BEHAVIOR (2018)
Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies
Richard J. Karpowicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
Stina Syvanen et al.
NEUROIMAGE (2017)
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Greta Hultqvist et al.
THERANOSTICS (2017)
Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
Xiaotian T. Fang et al.
BIOLOGICAL PROCEDURES ONLINE (2017)
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
Dag Sehlin et al.
NATURE COMMUNICATIONS (2016)
Alpha-Synuclein Oligomers-Neurotoxic Moleculesin Parkinson's Disease and Other Lewy Body Disorders
Martin Ingelsson
FRONTIERS IN NEUROSCIENCE (2016)
Use of 11C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders
Lieuwe Appel et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
Nishant N. Vaikath et al.
NEUROBIOLOGY OF DISEASE (2015)
Molecular Imaging Insights into Neurodegeneration: Focus on α-Synuclein Radiotracers
Maliha Shah et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Jens Niewoehner et al.
NEURON (2014)
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation
Therese Fagerqvist et al.
JOURNAL OF NEUROCHEMISTRY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking
Bong-Kyu Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Synthesis and in vitro evaluation of α-synuclein ligands
Lihai Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (Line 61) Mice
Marie-Francoise Chesselet et al.
NEUROTHERAPEUTICS (2012)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration
Jeffrey L. Cummings et al.
BRAIN (2011)
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties
Thomas Nasstrom et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
In vivo visualization of α-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy
Akio Kikuchi et al.
BRAIN (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood-Brain Barrier Delivery in the Mouse
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
In vitro characterisation of BF227 binding to α-synuclein/Lewy bodies
Michelle T. Fodero-Tavoletti et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
In vitro high affinity α-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain
Liang Ye et al.
JOURNAL OF NEUROCHEMISTRY (2008)
In vitro characterization of Pittsburgh compound-B binding to Lewy bodies
Michelle T. Fodero-Tavoletti et al.
JOURNAL OF NEUROSCIENCE (2007)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies
DJ Burn et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies
V. Deramecourt et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR
H Heise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Vesicular neurotransmitter transporters in Huntington's disease: Initial observations and comparison with traditional synaptic markers
M Suzuki et al.
SYNAPSE (2001)
Impaired dopaminergic neurotransmission in patients with traumatic brain injury:: a SPET study using 123I-β-CIT and 123I-IBZM
E Donnemiller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain
PJ Kahle et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
